XSHG603041
Market cap266mUSD
Dec 26, Last price
10.75CNY
1D
0.66%
1Q
9.25%
IPO
-26.42%
Name
Jiangsu Maysta Chemical Co Ltd
Chart & Performance
Profile
Jiangsu Maysta Chemical Co., Ltd. engages in the research and development, production, and sale of organosilicon surfactants in China and internationally. The company offers PU foam stabilizers for rigid foams, slab stock foams, HR foams, shoe soles, OCF, and rigid foam and HR foam cell openers; and PU catalysts for rigid and flexible foams. Its products are used in various sectors, such as home appliances, furniture, architecture, automobiles, etc. The company was founded in 2000 and is headquartered in Nanjing, China. Jiangsu Maysta Chemical Co., Ltd. is a subsidiary of Foshan Shunde District Demei Chemical Group Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 501,006 0.85% | 496,787 0.37% | 494,956 27.06% | |||||||
Cost of revenue | 359,984 | 412,147 | 418,600 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 141,022 | 84,641 | 76,355 | |||||||
NOPBT Margin | 28.15% | 17.04% | 15.43% | |||||||
Operating Taxes | 18,996 | 10,548 | 7,658 | |||||||
Tax Rate | 13.47% | 12.46% | 10.03% | |||||||
NOPAT | 122,026 | 74,093 | 68,697 | |||||||
Net income | 109,997 39.36% | 78,931 23.68% | 63,816 -42.49% | |||||||
Dividends | (25,364) | (20,146) | (33,812) | |||||||
Dividend yield | 1.05% | 0.99% | 1.94% | |||||||
Proceeds from repurchase of equity | (24,940) | |||||||||
BB yield | 1.23% | |||||||||
Debt | ||||||||||
Debt current | (22,845) | 198 | 238 | |||||||
Long-term debt | 263 | 561 | 238 | |||||||
Deferred revenue | 4,498 | 4,946 | 5,726 | |||||||
Other long-term liabilities | 1 | |||||||||
Net debt | (754,676) | (839,401) | (608,719) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 65,608 | 73,584 | 78,559 | |||||||
CAPEX | (207,919) | |||||||||
Cash from investing activities | (105,098) | |||||||||
Cash from financing activities | (20,726) | 371,920 | ||||||||
FCF | (186,180) | (62,835) | 82,232 | |||||||
Balance | ||||||||||
Cash | 694,323 | 840,160 | 579,597 | |||||||
Long term investments | 37,771 | 29,597 | ||||||||
Excess cash | 707,043 | 815,321 | 584,446 | |||||||
Stockholders' equity | 761,299 | 716,031 | 638,530 | |||||||
Invested Capital | 763,692 | 654,274 | 342,981 | |||||||
ROIC | 17.21% | 14.86% | 21.68% | |||||||
ROCE | 9.58% | 6.17% | 8.23% | |||||||
EV | ||||||||||
Common stock shares outstanding | 180,324 | 181,148 | 140,883 | |||||||
Price | 13.46 19.96% | 11.22 -9.44% | 12.39 -14.96% | |||||||
Market cap | 2,427,157 19.42% | 2,032,478 16.44% | 1,745,538 -14.66% | |||||||
EV | 1,674,252 | 1,195,046 | 1,138,802 | |||||||
EBITDA | 160,496 | 102,735 | 93,507 | |||||||
EV/EBITDA | 10.43 | 11.63 | 12.18 | |||||||
Interest | 556 | 53 | 19 | |||||||
Interest/NOPBT | 0.39% | 0.06% | 0.02% |